CNQ · LUFF.CN
Luff Enterprises Ltd.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
CNQ · GABY.CN · CAD
Stock price, earnings
Quote as of Jun 13, 2023, 05:05 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
GABY Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow GABY Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
GABY Inc., through its subsidiaries, is engaged in the manufacturing, promotion, distribution, and retail sale of cannabis-related consumer packaged goods across the United States. The firm's offerings span a broad array of cannabis products, such as packaged flower, concentrated extracts, pre-rolled items, edibles, topical applications, tinctures, and other goods infused with or derived from cannabis or hemp. These cannabis products are marketed under the brand names Mankind, Kind Republic, Lulu's, 2Rise, and Dank Space. Established in 2003, the company was formerly known as Gabriella's Kitchen Inc. before rebranding as GABY Inc. in September 2019. GABY Inc. maintains its headquarters in Calgary, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.10-CA$0.04 (-25.93%)
Awakn Life Sciences Corp.: Healthcare · Biotechnology.
CA$0.08CA$0.00 (0.0%)
Bloom Health Partners Inc.’s quoted price sits in the lower half of its reported 52-week range, 81.4% below the high.
CA$0.04CA$0.00 (0.0%)
Empower Clinics Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
CA$0.12+CA$0.03 (+26.32%)
Refined Metals Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.02CA$0.00 (0.0%)
ManifestSeven Holdings Corporation: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.36CA$0.00 (0.0%)
Acerus Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 96.4% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
